These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 8977749)

  • 1. Bone turnover and bone mineral density in patients with congenital adrenal hyperplasia.
    Guo CY; Weetman AP; Eastell R
    Clin Endocrinol (Oxf); 1996 Nov; 45(5):535-41. PubMed ID: 8977749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone mineral density, bone markers, and fractures in adult males with congenital adrenal hyperplasia.
    Falhammar H; Filipsson Nyström H; Wedell A; Brismar K; Thorén M
    Eur J Endocrinol; 2013 Mar; 168(3):331-41. PubMed ID: 23211577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone mineral density is not significantly reduced in adult patients on low-dose glucocorticoid replacement therapy.
    Koetz KR; Ventz M; Diederich S; Quinkler M
    J Clin Endocrinol Metab; 2012 Jan; 97(1):85-92. PubMed ID: 21994966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced bone mineral density and increased bone metabolism rate in young adult patients with 21-hydroxylase deficiency.
    Sciannamblo M; Russo G; Cuccato D; Chiumello G; Mora S
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4453-8. PubMed ID: 16926248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal changes of bone mineral density and bone turnover in postmenopausal women on thyroxine.
    Guo CY; Weetman AP; Eastell R
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):301-7. PubMed ID: 9156039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone mineral density and body composition in prepubertal and adolescent patients with the classical form of 21-hydroxylase deficiency.
    Sahakitrungruang T; Wacharasindhu S; Supornsilchai V; Srivuthana S; Kingpetch K
    J Med Assoc Thai; 2008 May; 91(5):705-10. PubMed ID: 18672636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term corticosteroid replacement and bone mineral density in adult women with classical congenital adrenal hyperplasia.
    King JA; Wisniewski AB; Bankowski BJ; Carson KA; Zacur HA; Migeon CJ
    J Clin Endocrinol Metab; 2006 Mar; 91(3):865-9. PubMed ID: 16278269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortical bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    El-Maouche D; Collier S; Prasad M; Reynolds JC; Merke DP
    Clin Endocrinol (Oxf); 2015 Mar; 82(3):330-7. PubMed ID: 24862755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone mineral density in girls with classical congenital adrenal hyperplasia due to CYP21 deficiency.
    Elnecave RH; Kopacek C; Rigatto M; Keller Brenner J; Sisson de Castro JA
    J Pediatr Endocrinol Metab; 2008 Dec; 21(12):1155-62. PubMed ID: 19189689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of glucocorticoid replacement therapy on bone mineral density in children with congenital adrenal hyperplasia.
    Cetinkaya S; Kara C
    J Pediatr Endocrinol Metab; 2011; 24(5-6):265-9. PubMed ID: 21823521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fractures and bone mineral density in adult women with 21-hydroxylase deficiency.
    Falhammar H; Filipsson H; Holmdahl G; Janson PO; Nordenskjöld A; Hagenfeldt K; Thorén M
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4643-9. PubMed ID: 17878254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone mineral density and body composition in congenital adrenal hyperplasia.
    Cameron FJ; Kaymakci B; Byrt EA; Ebeling PR; Warne GL; Wark JD
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2238-43. PubMed ID: 7608286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactinomas in adolescents: persistent bone loss after 2 years of prolactin normalization.
    Colao A; Di Somma C; Loche S; Di Sarno A; Klain M; Pivonello R; Pietrosante M; Salvatore M; Lombardi G
    Clin Endocrinol (Oxf); 2000 Mar; 52(3):319-27. PubMed ID: 10718830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of long-term glucocorticoid therapy on bone mineral density of the patients with congenital adrenal hyperplasia.
    Ünal S; Alikaşifoğlu A; Özön A; Gönç N; Kandemir N
    Turk J Pediatr; 2020; 62(3):359-366. PubMed ID: 32558409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal bone mineral density and lean body mass, but increased fat mass, in young adult patients with congenital adrenal hyperplasia.
    Stikkelbroeck NM; Oyen WJ; van der Wilt GJ; Hermus AR; Otten BJ
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1036-42. PubMed ID: 12629082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone Mass in Young Patients with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency.
    Espinosa Reyes TM; Leyva González G; Domínguez Alonso E; Falhammar H
    Horm Res Paediatr; 2021; 94(1-2):1-8. PubMed ID: 34044395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of Bone Mineral Parameters with Anthropometric Measurements and the Effect of Glucocorticoids on Bone Mineral Parameters in Congenital Adrenal Hyperplasia.
    Ganesh R; Suresh N; Janakiraman L; Ravikumar K
    Indian J Pediatr; 2016 Feb; 83(2):126-30. PubMed ID: 26223873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BclI polymorphism of the glucocorticoid receptor gene is associated with increased bone resorption in patients on glucocorticoid replacement therapy.
    Koetz KR; van Rossum EF; Ventz M; Diederich S; Quinkler M
    Clin Endocrinol (Oxf); 2013 Jun; 78(6):831-7. PubMed ID: 23134110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of glucocorticoid replacement therapy on growth, bone mineral density, and bone turnover markers in children with congenital adrenal hyperplasia.
    Girgis R; Winter JS
    J Clin Endocrinol Metab; 1997 Dec; 82(12):3926-9. PubMed ID: 9398689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone mineral density and bone turnover in relation to serum leptin, alpha-ketoglutarate and sex steroids in overweight and obese postmenopausal women.
    Filip R; Raszewski G
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):214-20. PubMed ID: 18547340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.